Literature DB >> 25480609

Clinical outcomes of early gastric cancer with lymphovascular invasion or positive vertical resection margin after endoscopic submucosal dissection.

Geum Youb Noh1, Ha Ra Ku, Youn Joo Kim, Su Cheol Park, Jin Kim, Chul Ju Han, Yu Chul Kim, Ki Young Yang.   

Abstract

BACKGROUND: In early gastric cancer (EGC) cases with lymphovascular invasion or positive vertical margins after endoscopic submucosal dissection (ESD), additional radical gastrectomy is performed on principle. However, an additional surgery is often difficult to consider if the surgical approach itself is challenging or the patient refuses surgery. In such cases, only close surveillance is performed without additional surgical procedures. This study aimed to examine the difference in clinical prognosis of EGC cases with lymphovascular invasion or positive vertical margins after ESD either with or without surgery.
METHODS: We retrospectively studied 83 patients with lymphovascular invasion or positive vertical margins after ESD from July 2005 to November 2013.
RESULTS: Of the 83 patients, 45 (54.2%) underwent radical additional gastrectomy (surgical group) and 38 (45.8%) were under close surveillance without surgical or endoscopic treatments (close surveillance group.) The cancer-free survival period was 78.3 ± 3.4 months in the surgical group and 64.5 ± 4.6 months in the close surveillance group. The recurrence rates did not significantly differ between the 2 groups, at 7.9% in the surgical group and 6.7% in the non-surgical group.
CONCLUSIONS: Close surveillance may be suggested as an option for EGC patients for whom a surgical approach is difficult, who exhibit a positive vertical margin after ESD, and who have no lymphovascular or deep submucosa invasion after ESD.

Entities:  

Mesh:

Year:  2014        PMID: 25480609     DOI: 10.1007/s00464-014-3973-0

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  18 in total

1.  Treatment strategy after non-curative endoscopic resection of early gastric cancer.

Authors:  I Oda; T Gotoda; M Sasako; T Sano; H Katai; T Fukagawa; T Shimoda; F Emura; D Saito
Journal:  Br J Surg       Date:  2008-12       Impact factor: 6.939

2.  Clinical outcomes of early gastric cancer with lateral margin positivity after endoscopic submucosal dissection.

Authors:  Jae Pil Han; Su Jin Hong; Moon Han Choi; Jeong-Yeop Song; Hee Kyung Kim; Bong Min Ko; Joo Young Cho; Joon Seong Lee; Moon Sung Lee
Journal:  Gastrointest Endosc       Date:  2013-07-31       Impact factor: 9.427

3.  Japanese gastric cancer treatment guidelines 2010 (ver. 3).

Authors: 
Journal:  Gastric Cancer       Date:  2011-06       Impact factor: 7.370

4.  Endoscopic submucosal dissection for residual early gastric cancer after endoscopic submucosal dissection.

Authors:  Makoto Higashimaya; Shiro Oka; Shinji Tanaka; Norifumi Numata; Yoji Sanomura; Shigeto Yoshida; Koji Arihiro; Kazuaki Chayama
Journal:  Gastrointest Endosc       Date:  2012-12-01       Impact factor: 9.427

Review 5.  Endoscopic treatment for early gastric cancer.

Authors:  Yang Won Min; Byung-Hoon Min; Jun Haeng Lee; Jae J Kim
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

6.  Indications for gastrectomy after incomplete EMR for early gastric cancer.

Authors:  Hideki Nagano; Shigekazu Ohyama; Tetsu Fukunaga; Yasuyuki Seto; Junko Fujisaki; Toshiharu Yamaguchi; Noriko Yamamoto; Yo Kato; Akio Yamaguchi
Journal:  Gastric Cancer       Date:  2005       Impact factor: 7.370

7.  Endoscopic and oncologic outcomes after endoscopic resection for early gastric cancer: 1370 cases of absolute and extended indications.

Authors:  Ji Yong Ahn; Hwoon-Yong Jung; Kee Don Choi; Ji Young Choi; Mi-Young Kim; Jeong Hoon Lee; Kwi-Sook Choi; Do Hoon Kim; Ho June Song; Gin Hyug Lee; Jin-Ho Kim; Young Soo Park
Journal:  Gastrointest Endosc       Date:  2011-07-13       Impact factor: 9.427

8.  Secondary endoscopic submucosal dissection for residual or recurrent tumors after gastric endoscopic submucosal dissection.

Authors:  Shu Hoteya; Toshiro Iizuka; Daisuke Kikuchi; Toshifumi Mitani; Akira Matsui; Osamu Ogawa; Tsukasa Furuhata; Satoshi Yamashta; Akihiro Yamada; Mitsuru Kaise; Naohisa Yahagi
Journal:  Gastric Cancer       Date:  2013-12-06       Impact factor: 7.370

9.  Surgical outcome after incomplete endoscopic submucosal dissection of gastric cancer.

Authors:  H Jung; J M Bae; M G Choi; J H Noh; T S Sohn; S Kim
Journal:  Br J Surg       Date:  2010-11-04       Impact factor: 6.939

10.  Should elderly patients undergo additional surgery after non-curative endoscopic resection for early gastric cancer? Long-term comparative outcomes.

Authors:  Chika Kusano; Motoki Iwasaki; Tonya Kaltenbach; Abby Conlin; Ichiro Oda; Takuji Gotoda
Journal:  Am J Gastroenterol       Date:  2011-03-15       Impact factor: 10.864

View more
  10 in total

1.  Clinical outcomes of early gastric cancer patients after noncurative endoscopic submucosal dissection in a large consecutive patient series.

Authors:  Haruhisa Suzuki; Ichiro Oda; Seiichiro Abe; Masau Sekiguchi; Satoru Nonaka; Shigetaka Yoshinaga; Yutaka Saito; Takeo Fukagawa; Hitoshi Katai
Journal:  Gastric Cancer       Date:  2016-10-08       Impact factor: 7.370

2.  Impact of non-curative endoscopic submucosal dissection on short- and long-term outcome of subsequent laparoscopic gastrectomy for pT1 gastric cancer.

Authors:  Shoji Shimada; Naruhiko Sawada; Sonoko Oae; Junichi Seki; Yojiro Takano; Kenta Nakahara; Yusuke Takehara; Shumpei Mukai; Fumio Ishida; Shin-Ei Kudo
Journal:  Surg Endosc       Date:  2021-09-07       Impact factor: 3.453

3.  Risk Factors Associated with Lymph Node Metastasis for Early Gastric Cancer Patients Who Underwent Non-curative Endoscopic Resection: a Systematic Review and Meta-analysis.

Authors:  Bochao Zhao; Jingting Zhang; Jiale Zhang; Rui Luo; Zhenning Wang; Huimian Xu; Baojun Huang
Journal:  J Gastrointest Surg       Date:  2018-09-04       Impact factor: 3.452

Review 4.  Resection line involvement after gastric cancer treatment: handle with care.

Authors:  Paolo Morgagni; Giuliano La Barba; Eleonora Colciago; Giovanni Vittimberga; Giorgio Ercolani
Journal:  Updates Surg       Date:  2018-06-23

5.  Predictors of lymph node metastasis and residual tumor in early gastric cancer patients after noncurative endoscopic resection: a systematic review and meta-analysis.

Authors:  Bolun Jiang; Li Zhou; Jun Lu; Yizhi Wang; Junchao Guo
Journal:  Therap Adv Gastroenterol       Date:  2020-06-23       Impact factor: 4.409

6.  Cost Analysis of Endoscopic Submucosal Dissection for the Treatment of Colorectal Lesions in China.

Authors:  Ning Cui; Yu Zhao; Honggang Yu
Journal:  Biomed Res Int       Date:  2019-03-26       Impact factor: 3.411

Review 7.  Additional gastrectomy in early-stage gastric cancer after non-curative endoscopic resection: a meta-analysis.

Authors:  Run-Cong Nie; Shu-Qiang Yuan; Yuan-Fang Li; Shi Chen; Yong-Ming Chen; Xiao-Jiang Chen; Guo-Ming Chen; Zhi-Wei Zhou; Ying-Bo Chen
Journal:  Gastroenterol Rep (Oxf)       Date:  2019-03-08

8.  Additional laparoscopic gastrectomy after noncurative endoscopic submucosal dissection for early gastric cancer: A single-center experience.

Authors:  Yan-Tao Tian; Fu-Hai Ma; Gui-Qi Wang; Yue-Ming Zhang; Li-Zhou Dou; Yi-Bin Xie; Yu-Xin Zhong; Ying-Tai Chen; Quan Xu; Dong-Bing Zhao
Journal:  World J Gastroenterol       Date:  2019-08-07       Impact factor: 5.742

Review 9.  A Comprehensive and Comparative Review of Global Gastric Cancer Treatment Guidelines.

Authors:  Sang Soo Eom; Wonyoung Choi; Bang Wool Eom; Sin Hye Park; Soo Jin Kim; Young Il Kim; Hong Man Yoon; Jong Yeul Lee; Chan Gyoo Kim; Hark Kyun Kim; Myeong-Cherl Kook; Il Ju Choi; Young-Woo Kim; Young Iee Park; Keun Won Ryu
Journal:  J Gastric Cancer       Date:  2022-03-31       Impact factor: 3.720

10.  Patterns of Lymph Node Metastasis in Patients With T1/T2 Gastroduodenal Neuroendocrine Neoplasms: Implications for Endoscopic Treatment.

Authors:  Yu-Jie Zhou; Qi-Wen Wang; Qing-Wei Zhang; Jin-Nan Chen; Xin-Yuan Wang; Yun-Jie Gao; Xiao-Bo Li
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-28       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.